Sandoz pagará US$ 450 milhões para encerrar litígios antitruste nos EUA

Sandoz strikes US settlements to resolve generic drug price dispute

Swiss pharmaceutical group Sandoz on Monday announced two amicable settlements in the United States, totalling $478.5 million, to resolve a long-running dispute related to generic drug pricing.